BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12737859)

  • 1. Tolerogenic immunosuppression for organ transplantation.
    Starzl TE; Murase N; Abu-Elmagd K; Gray EA; Shapiro R; Eghtesad B; Corry RJ; Jordan ML; Fontes P; Gayowski T; Bond G; Scantlebury VP; Potdar S; Randhawa P; Wu T; Zeevi A; Nalesnik MA; Woodward J; Marcos A; Trucco M; Demetris AJ; Fung JJ
    Lancet; 2003 May; 361(9368):1502-10. PubMed ID: 12737859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
    Shapiro R; Jordan ML; Basu A; Scantlebury V; Potdar S; Tan HP; Gray EA; Randhawa PS; Murase N; Zeevi A; Demetris AJ; Woodward J; Marcos A; Fung JJ; Starzl TE
    Ann Surg; 2003 Oct; 238(4):520-5; discussion 525-7. PubMed ID: 14530723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards clinical transplantation tolerance.
    Claas FH
    Lancet; 2003 May; 361(9368):1489-90. PubMed ID: 12737855
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.
    Abu-Elmagd KM; Costa G; Bond GJ; Wu T; Murase N; Zeevi A; Simmons R; Soltys K; Sindhi R; Stein W; Demetris A; Mazariegos G
    Transpl Int; 2009 Jan; 22(1):96-109. PubMed ID: 18954362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.
    Shapiro R; Basu A; Tan H; Gray E; Kahn A; Randhawa P; Murase N; Zeevi A; Girnita A; Metes D; Ness R; Bass DC; Demetris AJ; Fung JJ; Marcos A; Starzl TE
    J Am Coll Surg; 2005 Apr; 200(4):505-15; quiz A59-61. PubMed ID: 15804464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.
    Stevens RB; Foster KW; Miles CD; Lane JT; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Nielsen KJ; Skorupa JY; Kellogg AM; Malik T; Wrenshall LE
    Transplantation; 2015 Jan; 99(1):197-209. PubMed ID: 25083614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation.
    Shapiro R; Ellis D; Tan HP; Moritz ML; Basu A; Vats AN; Khan AS; Gray EA; Zeevi A; McFeaters C; James G; Jo Grosso M; Marcos A; Starzl TE
    J Pediatr; 2006 Jun; 148(6):813-8. PubMed ID: 16769394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior Patient and Graft Survival in Adult Liver Transplant with Rabbit Antithymocyte Globulin Induction: Experience with 595 Patients.
    Montenovo MI; Jalikis FG; Li M; Yeh M; Dick A; Hansen R; Reyes JD
    Exp Clin Transplant; 2017 Aug; 15(4):425-431. PubMed ID: 27309029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.
    Abu-Elmagd KM; Costa G; Bond GJ; Soltys K; Martin L; Koritsky DA; Cunha-Melo JR; Sogawa H; Irish W; Tzakis A; Mazariegos G
    Clin Transpl; 2012; ():155-66. PubMed ID: 23721018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
    Khanmoradi K; Knorr JP; Feyssa EL; Parsikia A; Jawa P; Dinh DB; Campos S; Zaki RF; Ortiz JA
    Exp Clin Transplant; 2013 Jun; 11(3):222-8. PubMed ID: 23432665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW; Sutherland DE; Drangstveit MB; Wrenshall L; Humar A; Gruessner AC
    Transplantation; 1998 Aug; 66(3):318-23. PubMed ID: 9721799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced dose Thymoglobulin, tacrolimus, and mofetil mycophenolate results in excellent solitary pancreas transplantation outcomes.
    Tan M; Cantarovich M; Mangel R; Paraskevas S; Fortier M; Metrakos P
    Clin Transplant; 2002 Dec; 16(6):414-8. PubMed ID: 12437620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantation.
    De Ruvo N; Cucchetti A; Lauro A; Masetti M; Cautero N; Di Benedetto F; Dazzi A; Del Gaudio M; Ravaioli M; Di Francesco F; Molteni G; Ramacciato G; Risaliti A; Pinna AD
    Transplantation; 2005 Jul; 80(1):8-12. PubMed ID: 16003226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
    Stratta RJ; Alloway RR; Hodge E; Lo A;
    Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus and Single Intraoperative High-dose of Anti-T-lymphocyte Globulins Versus Tacrolimus Monotherapy in Adult Liver Transplantation: One-year Results of an Investigator-driven Randomized Controlled Trial.
    Iesari S; Ackenine K; Foguenne M; De Reyck C; Komuta M; Bonaccorsi Riani E; Ciccarelli O; Coubeau L; Lai Q; Gianello P; Lerut J
    Ann Surg; 2018 Nov; 268(5):776-783. PubMed ID: 30307410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of immunosuppressive usage in pancreas transplantation.
    Stratta RJ
    Clin Transplant; 1999 Feb; 13(1 Pt 1):1-12. PubMed ID: 10081628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.